Cepheid (CPHD) Tops Q1 EPS by 9c; Issues Mixed FY11 Outlook
Tweet
Share
E-mailGet Alerts CPHD Hot Sheet
Price: $52.95 --0%
Financial Fact:
Benefit from (provision for) income taxes: -1.19M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Benefit from (provision for) income taxes: -1.19M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Cepheid (NASDAQ: CPHD) reported Q1 EPS of $0.08, $0.09 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $60.22 million versus the consensus estimate of $57.26 million.
Sees FY2011 EPS of $0.31-$0.36, versus the consensus of $0.07. Also sees FY2011 revenue of $245-$255 million, versus the consensus of $253.55 million.
Sees FY2011 EPS of $0.31-$0.36, versus the consensus of $0.07. Also sees FY2011 revenue of $245-$255 million, versus the consensus of $253.55 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
- Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
